Results 331 to 340 of about 114,159 (384)

Infections of the Oropharynx

Emergency Medicine Clinics of North America, 2019
This article reviews the presentation, diagnosis, and management of common and "can't miss" infections of the oropharynx, including streptococcal pharyngitis, infectious mononucleosis, peritonsillar abscess, retropharyngeal abscess, and epiglottitis.
M. Klein
openaire   +3 more sources

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

, 2020
6500Background: ECOG-ACRIN 3311 examines reduced postoperative therapy in patients with “intermediate risk” p16+ oropharynx cancer (OPC) undergoing primary transoral surgical management.
R. Ferris, Yael Flamand, G. Weinstein, Shuli Li, H. Quon, R. Mehra, Joaquín J. García, C. Chung, M. Gillison, U. Duvvuri, B. O'Malley, E. Ozer, G. Thomas, W. Koch, M. Kupferman, R. Bell, N. Saba, M. Lango, Eduardo Mendez, B. Burtness   +19 more
semanticscholar   +1 more source

Treatment modality impact on quality of life for human papillomavirus–associated oropharynx cancer

The Laryngoscope, 2020
Compare treatment‐related quality of life (QOL) impact for early‐stage human papillomavirus–associated oropharynx squamous cell carcinoma (HPV+ OPSCC) patients.
M. Xu, Karolina A Plonowska, Z. R. Gurman, Amanda K Humphrey, P. Ha, Steven J. Wang, I. El-Sayed, Chase M. Heaton, Jonathan R. George, S. Yom, A. Algazi, W. Ryan   +11 more
semanticscholar   +1 more source

Neoadjuvant chemotherapy followed by surgery for HPV‐associated locoregionally advanced oropharynx cancer

Head and Neck, 2020
Neoadjuvant chemotherapy followed by surgery (NAC + S), a paradigm based on systemic escalation coupled with surgery‐based de‐escalation, is under investigation for treatment of HPV‐associated oropharynx cancer (OPC).
N. Sadeghi, M. Mascarella, S. Khalife, A. Ramanakumar, Keith Richardson, A. Joshi, R. Taheri, A. Fuson, N. Bouganim, R. Siegel   +9 more
semanticscholar   +1 more source

HPV-related squamous cell carcinoma of oropharynx: a review

Journal of Clinical Pathology, 2020
In early 1930, R. E. Shope paved the way for the recognition of human papillomavirus (HPV) as a causative agent of some types of cancers. In early 2000, the relationship between HPV and a subset of head and neck cancers, mostly located in the oropharynx,
S. Rahimi
semanticscholar   +1 more source

Predictors of Mortality in HPV‐Associated Oropharynx Carcinoma Treated With Surgery Alone

The Laryngoscope, 2020
Survival outcomes for human papillomavirus‐associated oropharynx squamous cell carcinoma (HPV + OPSCC) treated with surgery alone are unclear. To increase understanding, we assessed overall survival (OS) outcomes using the national cancer database (NCDB).
Mary Han, G. Stanford-Moore, Andrew R. Larson, David W. Schoppy, D. Cognetti, A. Joshi, Jeffery J. Houlton, W. Ryan   +7 more
semanticscholar   +1 more source

Pathologic response to neoadjuvant chemotherapy in HPV‐associated oropharynx cancer

Head and Neck, 2019
A paradigm shift has led to de‐escalation trials for the treatment of HPV‐positive oropharynx cancer (OPC). The objective of this study was to assess the ability of tumor volume reduction on imaging to predict pathological response to neoadjuvant ...
N. Sadeghi, S. Khalife, M. Mascarella, A. Ramanakumar, Keith Richardson, A. Joshi, N. Bouganim, R. Taheri, A. Fuson, R. Siegel   +9 more
semanticscholar   +1 more source

Cancer of the oropharynx

Critical Reviews in Oncology/Hematology, 2002
Oropharyngeal cancer is a rare tumour. Tobacco use and alcohol consumption are recognised as major risk factors. Several carcinogens, occupational exposures and vitamin deficiencies represent the most significant predisposing factors. A varying host susceptibility to carcinogens can be inferred.
L. Licitra, Bernier, J., Grandi, C., Merlano, M., Bruzzi, P., Lefebvre, J. -.L.   +5 more
openaire   +3 more sources

TRPM8, ASIC1, and ASIC3 localization and expression in the human oropharynx

Neurogastroenterology and Motility, 2018
Oropharyngeal dysphagia (OD) is a prevalent disease with poor prognosis among older people and has no pharmacological treatment. Polymodal sensory receptors like the TRP or ASIC family receptors are potential targets to treat OD.
D. Álvarez-Berdugo, L. Rofes, J. F. Casamitjana, A. Enrique, J. Chamizo, C. Viña, C. Pollan, P. Clavé   +7 more
semanticscholar   +1 more source

Nasopharynx and Oropharynx

2016
The oropharynx and nasopharynx are the sites of common infectious diseases, as well as a wide variety of malformative and neoplastic lesions, requiring differential diagnosis. The epidemiologic, aetiopathogenetic, morphological and molecular features of these entities are discussed.
Franchi, Alessandro, Palomba, Annarita, El-Mofty, Samir K.   +2 more
openaire   +2 more sources